Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells (CSM/ON/2011)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by Red de Terapia Celular.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
Spanish National Health System
Information provided by (Responsible Party):
Red de Terapia Celular
ClinicalTrials.gov Identifier:
NCT01700920
First received: October 2, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given